CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
There is no consensus on the exact role of the adaptive immune system in Parkinson’s disease pathogenesis, although there is increasing evidence that it is somehow involved. Moreover, T cell infiltration in the brain has not been thoroughly studied in Parkinson’s disease and no study has assessed the infiltration in incidental Lewy body diseases cases that are considered to be early presymptomatic stages of the disease. In this study, we performed an immunohistochemistry/immunofluorescence quantitative and phenotypic assessment of T cell infiltration in human substantia nigra pars compacta and analysed the correlations with neuronal death and synucleinopathy throughout different stages of the disease. We included two groups of incidental Lewy disease in the study. One of the groups, which is believed to be the earliest stage of the disease, showed α-synuclein aggregates only in the olfactory bulb. The second group also presented α-synuclein aggregates in the substantia nigra. We also assessed the formation of different α-synuclein aggregates throughout the different stages of the unified staging system for Lewy body disorders (I to IV). We found that CD8 T cells were increased in diagnosed Parkinson’s disease cases compared to the control group and their density positively correlated with neuronal death. Some of the infiltrating CD8 T cells were indeed contacting dopaminergic neurons. No differences were found regarding CD4 T cells. In the earliest stage of the disease, when substantia nigra α-synuclein aggregation is absent, we found a robust CD8 T cell infiltration and no dopaminergic neuronal death yet. Conversely, in the next stage we found neuronal loss and a milder CD8 T cell infiltration. CD8 T cell infiltration paralleled that of α-synuclein accumulation and neuronal death throughout stages II to IV. We also confirmed that CD8 T cells in charge of immune surveillance and involved in the aetiopathogenesis of the disease are equipped with cytolytic enzymes (granzyme A, B and K) and/or proinflammatory cytokines (interferon gamma), and that phenotypic differences were observed between early and late stages of the disease. We also demonstrate that a high proportion of nigral CD8 T cells are tissue resident memory T cells. Our results show that nigral cytotoxic CD8 T cell infiltration is an earlier pathogenic event than α-synuclein aggregation and neuronal death and that it parallels the progression of neuronal death and synucleinopathy in Parkinson’s disease. Overall, our study suggests that CD8 T cell cytotoxic attack may initiate and propagate neuronal death and synucleinopathy in Parkinson’s disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other authors have demonstrated that cytotoxic CD8 + T cell infiltration occurred earlier than a-synuclein aggregation and neuronal death, suggesting adaptive immune system involvement.87”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [87]
Citations
Cites
1 retracted
Chandra, G., Rangasamy, S. B., Roy, A., Kordower, J. H., & Pahan, K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.714824 · Cited by 90
RetractedStaging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
Perforin and granzymes: function, dysfunction and human pathology
Voskoboinik, I., Whisstock, J. C., & Trapani, J. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3839 · Cited by 1,327
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Castro, F., Cardoso, A. P., Gonçalves, R. M., Serre, K., & Oliveira, M. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00847 · Cited by 1,224
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866
Hamza, T. H., Zabetian, C. P., Tenesa, A., Laederach, A., Montimurro, J., Yearout, D., Kay, D. M., Doheny, K. F., Paschall, J., Pugh, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.642 · Cited by 784
the Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Lue, L., Sue, L. I., Bachalakuri, J., Henry-Watson, J., Sasse, J., Boyer, S., Shirohi, S., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0538-8 · Cited by 698
Understanding Dopaminergic Cell Death Pathways in Parkinson Disease
Michel, P. P., Hirsch, E. C., & Hunot, S. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.038 · Cited by 600
Research works printed but not linked: 1
- Mosley, 2012, Inflammation and adaptive immunity in Parkinson’s disease. Cold Spring Harb, Perspect Med, 2, 1
Cited by
Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions
Dong-Chen, X., Yong, C., Yang, X., Chen-Yu, S., & Li-Hua, P. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01353-3 · Cited by 469
“For example, CD4 and CD8 T cells significantly infiltrated into the SN of patients with PD,160 with CD8 T-cell concentrations particularly high.(176,177) Because this infiltration occurs in early-stage PD and subsides with disease progression, CD8 T cells seem to be important at the beginning of the disease.”
BackgroundNeuroinflammation across neurological diseases
Shi, F.-D., & Yong, V. W. (2025) · Science · doi:10.1126/science.adx0043 · Cited by 274
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Blesa, J., Foffani, G., Dehay, B., Bezard, E., & Obeso, J. A. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00542-9 · Cited by 232
Schonhoff, A. M., Figge, D. A., Williams, G. P., Jurkuvenaite, A., Gallups, N. J., Childers, G. M., Webster, J. M., Standaert, D. G., Goldman, J. E., & Harms, A. S. (2023) · Nature Communications · doi:10.1038/s41467-023-39060-w · Cited by 161
“While recent studies have shown a role for CD8 T cells in the neuroinflammatory response to α-syn, their deleterious effects appear to be partially dependent on CD4 function and independent from BAMs[8, 26, 27].”
The immune system in Parkinson's disease: what we know so far
Roodveldt, C., Bernardino, L. I., Çakmak, Ö. Ö., Dragić, M., Fladmark, K. E., Ertan, S., Aktaş, B., Pita, C., Ciglar, L., Garraux, G., et al. (2024) · Brain · doi:10.1093/brain/awae177 · Cited by 173
“45,54,55 Infiltration of peripheral monocytes into the brain has not yet been definitively proven in humans due to a lack of efficient markers to distinguish monocytes from microglia.”
BackgroundBeyond the gut: decoding the gut–immune–brain axis in health and disease
Park, J. C., Chang, L., Kwon, H.-K., & Im, S.-H. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01333-3 · Cited by 149
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
Koeglsperger, T., Rumpf, S.-L., Schließer, P., Struebing, F. L., Brendel, M., Levin, J., Trenkwalder, C., Höglinger, G. U., & Herms, J. W. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00622-7 · Cited by 159
“The authors found that CD8positive T-lymphocytes were increased in the SNc of PD cases compared to the control group, whereas CD4positive T cells remained unchanged [92].”
ResultThe Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases
Zang, X., Chen, S., Zhu, J., Ma, J., & Zhai, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.872134 · Cited by 139
Goddery, E. N., Fain, C. E., Lipovsky, C., Ayasoufi, K., Yokanovich, L. T., Malo, C. S., Khadka, R. H., Tritz, Z. P., Jin, F., Hansen, M. J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.726421 · Cited by 141
α-Synuclein pathology as a target in neurodegenerative diseases
Park, H.-J., Kam, T., Dawson, V. L., & Dawson, T. M. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01043-w · Cited by 125
“Furthermore, CD8 + and CD4 + T cells have been observed in the substantia nigra of post-mortem brains of people with PD 283,284 .”
Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson’s disease mice
Karikari, A. A., McFleder, R. L., Ribechini, E., Blum, R., Bruttel, V., Knorr, S., Gehmeyr, M., Volkmann, J., Brotchie, J. M., Ahsan, F., et al. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.01.007 · Cited by 116
“Extensive S129 phosphorylation, which promotes α-synuclein fibril formation, is considered a specific marker of α-synucleinopathies (Fujiwara et al., 2002).”
BackgroundFrieser, D., Pignata, A., Khajavi, L., Shlesinger, D., Gonzalez-Fierro, C., Nguyen, X.-H., Yermanos, A., Merkler, D., Höftberger, R., Desestret, V., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl6157 · Cited by 102
Immune responses in the Parkinson's disease brain
Weiss, F. C., Labrador‐Garrido, A., Dzamko, N. L., & Halliday, G. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105700 · Cited by 104
Xu, Y., Li, Y., Wang, C., Han, T., Liu, H., Sun, L., Hong, J., Hashimoto, M., & Wei, J. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02723-y · Cited by 98
“It reveals that both types of T cells infiltrate the substantia nigra of the PD brain, with CD8+ T cells being the main type, which was activated by recognizing target cells expressing major histocompatibility complex (MHC)-I molecules and releasing lymphotoxins such as perforin and granzyme to directly kill the targe…”
BackgroundGrotemeyer, A., McFleder, R. L., Wu, J., Wischhusen, J., & Ip, C. W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.878771 · Cited by 90
“It is possible that CD8 T cells have an important role in early PD, even before paSYN can be detected in the SN, as relevant infiltration into the SN has been observed in very early PD that subsides with disease progression (74).”
BackgroundPadhi, P., Worth, C., Zenitsky, G. D., Jin, H., Sambamurti, K., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.836605 · Cited by 87
Groh, J., Feng, R., Yuan, X., Liu, L., Klein, D., Hutahaean, G., Butz, E., Wang, Z., Steinbrecher, L., Neher, J., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01955-w · Cited by 62
Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
Saramowicz, K., Siwecka, N., Galita, G., Kucharska-Lusina, A., Rozpędek‐Kamińska, W., & Majsterek, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010360 · Cited by 87
Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease
Kasen, A., Houck, C., Burmeister, A. R., Sha, Q., Brundin, L., & Brundin, P. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105654 · Cited by 78
The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
Deyell, J., Sriparna, M., Ying, M., & Mao, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032477 · Cited by 79
“There is some evidence that the microglial processing of α-syn facilitates CD8+ T cell activity to a greater extent than CD4+ T cell activity [125].”
Mediterranean Diet and Parkinson’s Disease
Bisaglia, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010042 · Cited by 83
Emerging roles of astrocytes as immune effectors in the central nervous system
Fisher, T. M., & Liddelow, S. A. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.08.008 · Cited by 78
Immune mechanisms and shared immune targets in neurodegenerative diseases
Weiner, H. L. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01046-7 · Cited by 73
“Multiple changes in T cells have been observed in PD. CD4 + and CD8 + T cells are present in the substantia nigra of people with PD 280,281 , peripheral blood T cells in people with PD recognize α-synuclein peptides 282 , and CD4 + T cells contribute to neurodegeneration in Lewy body dementia 283 .”
Lorente-Picón, M., & Laguna, A. (2021) · Biomolecules · doi:10.3390/biom11030433 · Cited by 69
“In addition, infiltration and accumulation of peripheral immune cells are also found in affected brain regions in PD patients [168].”
BackgroundRole of P2X7 Receptors in Immune Responses During Neurodegeneration
Oliveira-Giacomelli, Á., Petiz, L. L., Andrejew, R., Turrini, N., Silva, J. B., Sack, U., & Ulrich, H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.662935 · Cited by 68
How the immune system shapes neurodegenerative diseases
Mason, H. D., & McGavern, D. B. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.08.001 · Cited by 69
T Lymphocytes in Parkinson’s Disease
Contaldi, E., Magistrelli, L., & Comi, C. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223152 · Cited by 73
“Based on neuropathological evidence, a recent study [12] assessed T cell infiltration in human substantia nigra pars compacta (SNc) throughout different PD stages (one group with -synuclein aggregates”
BackgroundThe systemic immune response in Parkinson’s disease: focus on the peripheral immune component
Lauritsen, J., & Romero‐Ramos, M. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.07.005 · Cited by 74
Nissen, S. K., Farmen, K., Carstensen, M., Schulte, C., Goldeck, D., Brockmann, K., & Romero‐Ramos, M. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.01.005 · Cited by 69
“183 infiltrate the midbrain prior to the dopaminergic neuronal death (Galiano-Landeira et al., 2020).”
BackgroundNeuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies
Terkelsen, M. H., Klæstrup, I. H., Hvingelby, V. S., Lauritsen, J., Pavese, N., & Romero‐Ramos, M. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223245 · Cited by 72
“PD patients have Th1 and cytotoxic CD4 T cell and terminal effector CD8 T cell populations clonally expanded by T-cell receptor (TCR)-dependent activation [53].”
BackgroundInfluentialThe spatial landscape of glial pathology and T cell response in Parkinson’s disease substantia nigra
Ma, M., Paryani, F., Jakubiak, K. A., Xia, S., Antoku, S., Kannan, A., Lee, J., Madden, N., Kumar, S. S., Li, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62478-3 · Cited by 68
Specific immune status in Parkinson’s disease at different ages of onset
Tian, J., Dai, S., Jiang, S., Yang, W., Yan, Y., Lin, Z., Dong, J., Liu, Y., Zheng, R., Chen, Y., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-021-00271-x · Cited by 68
Inflammation as common link to progressive neurological diseases
Dias-Carvalho, A., Sá, S. I., Carvalho, F., Fernandes, E., & Costa, V. M. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03628-8 · Cited by 60
“…pars compacta of human post-mortem brain tissue was evaluated on patients featuring Lewy Bodies disease (only α-synuclein clumps deposition, which is considered to be the pre-symptomatic stages of PD), in patients with established PD and age-matched healthy controls (Galiano-Landeira et al. 2020).”
BackgroundInfluentialT Cells: A Growing Universe of Roles in Neurodegenerative Diseases
Dressman, D., & Elyaman, W. (2021) · The Neuroscientist · doi:10.1177/10738584211024907 · Cited by 66
Glial reactivity and T cell infiltration in frontotemporal lobar degeneration with tau pathology
Hartnell, I. J., Woodhouse, D., Jasper, W., Mason, L., Marwaha, P. K., Graffeuil, M., Lau, L. C., Norman, J. L., Chatelet, D. S., Buée, L., et al. (2023) · Brain · doi:10.1093/brain/awad309 · Cited by 64
The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
Jurcău, A., Andronie-Cioară, F. L., Nistor-Cseppento, C. D., Pașcalău, N., Rus, M., Vasca, E., & Jurcău, M. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914582 · Cited by 63
“CD8+ T cells are activated by recognizing MHC I molecules and release lymphotoxins, such as granzyme and perforin, to kill target cells [204].”
The role of the CD8+ T cell compartment in ageing and neurodegenerative disorders
Terrabuio, E., Zenaro, E., & Constantin, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1233870 · Cited by 56
“Notably, although a direct demonstration is still lacking, CD8+ T cells with a TRM phenotype were detected near altered neurons in the substantia nigra, suggesting that CD8+ T cells may exert cytotoxic functions potentially contributing to the pathological changes in PD (5) (Figure 2).”
BackgroundResultInfluentialCD8+ T cells in brain injury and neurodegeneration
Zhang, Z., Duan, Z., & Cui, Y. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1281763 · Cited by 55
The complex role of inflammation and gliotransmitters in Parkinson's disease
Gopinath, A., Mackie, P. M., Phan, L. T., Tansey, M. G., & Khoshbouei, H. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105940 · Cited by 55
Granzyme K+ CD8 T cells slow tauopathy progression by targeting microglia
Mason, H. D., Latour, Y. L., Boughter, C. T., Johnson, K. R., Maric, D., Dorrier, C., Guedes, V. A., Lai, C., Duncker, P. C., Johnson, A. M., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02198-4 · Cited by 54
“CD8 + and CD4 + T cells were also linked to neurogenerative diseases, including AD 20,29–33 , tauopathy 24,34 , Parkinson’s disease 22,25,35,36 and amyotrophic lateral sclerosis 37–39 , but T cell depletion in animal models has yielded different outcomes depending on the specific model, disease…”
Khan, M. S., Nasiripour, S., & Bopassa, J. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136416 · Cited by 57
Grotemeyer, A., Fischer, J. F., Koprich, J. B., Brotchie, J. M., Blum, R., Volkmann, J., & Ip, C. W. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02759-0 · Cited by 48
“Furthermore, CD8+ T cells are involved in the early stages of PD as they are found to precede pathαSYN in early PD patients [4].”
BackgroundDAT and TH expression marks human Parkinson’s disease in peripheral immune cells
Gopinath, A., Mackie, P. M., Hashimi, B., Buchanan, A. M., Smith, A. R., Bouchard, R. S., Shaw, G., Badov, M., Saadatpour, L., Gittis, A. H., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00333-8 · Cited by 48
Capelle, C., Ciré, S., Hedin, F., Hansen, M., Pavelka, L., Grzyb, K., Kyriakis, D., Hunewald, O. E., Konstantinou, M., Revets, D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43053-0 · Cited by 49
The Skin–Brain Axis: From UV and Pigmentation to Behaviour Modulation
Ascsillán, A. A., & Kemény, L. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116199 · Cited by 49
“…neuroprotective effects on immune cells to restore the blood–brain barrier (BBB)—disrupted by oxidative stress and neuroinflammation—[63] along with reversing nigral T-cell infiltration (precedes nigral synucleinopathy) [64] and ameliorating oxidative stress and apoptosis of affected neurons [65].”
BackgroundT lymphocyte senescence is attenuated in Parkinson’s disease
Kouli, A., Jensen, M. P., Papastavrou, V., Scott, K. M., Kolenda, C., Parker, C., Solim, I. H., Camacho, M., Martin-Ruiz, C. M., & Williams‐Gray, C. H. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02287-9 · Cited by 48
Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanisms
Schilder, B. M., Navarro, E., & Raj, T. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105580 · Cited by 48
“A recent study suggests that CD8+ T-cell infiltration is an early pathogenic event that precedes ɑ-synuclein aggregation and DA neuronal loss (Galiano-Landeira et al., 2020).”
Hong, H., Wang, Y., Menard, M. A., Buckley, J. A., Zhou, L., Volpicelli‐Daley, L. A., Standaert, D. G., Qin, H., & Benveniste, E. N. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03210-8 · Cited by 47
Berger–Sieczkowski, E., Endmayr, V., Haider, C., Ricken, G., Jauk, P., Macher, S., Pirker, W., Högl, B., Heidbreder, A., Schnider, P., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02625-6 · Cited by 43
Kimura, K., Nishigori, R., Hamatani, M., Sawamura, M., Ashida, S., Fujii, C., Takata, M., Lin, Y., Sato, W., Okamoto, T., et al. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200172 · Cited by 42
Gut–Brain Axis: Focus on Sex Differences in Neuroinflammation
Caldarelli, M., Rio, P., Marrone, A., Ocarino, F., Chiantore, M., Candelli, M., Gasbarrini, A., Gambassi, G., & Cianci, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105377 · Cited by 45
“For instance, CD4 + and CD8 + T cells infiltrate the CNS of patients with PD, especially CD8 T cells in the early stage of disease [55].”
BackgroundAlpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson’s Disease
Su, R., & Zhou, T. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.769506 · Cited by 36
Age-Related Midbrain Inflammation and Senescence in Parkinson’s Disease
Russo, T., & Rießland, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.917797 · Cited by 40
Impact of sex on neuroimmune contributions to Parkinson’s disease
Bourque, M., Morissette, M., Soulet, D., & Paolo, T. D. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110668 · Cited by 37
Changes of T lymphocyte subpopulations and their roles in predicting the risk of Parkinson’s disease
He, Y., Peng, K., Li, R., Zhang, Z., Pan, L., Zhang, T., Lin, A., Hong, R., Nie, Z., Guan, Q., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11190-z · Cited by 38
Neuronal Presentation of Antigen and Its Possible Role in Parkinson’s Disease
Hobson, B. D., & Sulzer, D. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223153 · Cited by 39
“CD8+ T cells are often identified near dopaminergic perikarya in the SN [19, 33, 34], and also near pigmented, MHC-I+ neuronal perikarya in the locus coeruleus [19].”
BackgroundPedersen, C. C., Ushakova, A., Skogseth, R. E., Alves, G. W., Tysnes, O., Aarsland, D., Lange, J., & Maple‐Grødem, J. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200132 · Cited by 40
“Notably, a postmortem study of patients with PD found an association between the increase in CD8 T-cell infiltration and the increase in the presence of α-synuclein (α-syn) aggregation and subsequent dopaminergic neuronal death.(41)Because these are both hallmarks of PD pathology, this shows that CD8A plays a role in…”
BackgroundWang, K., Zhang, C., Zhang, B., Li, G., Shi, G., Cai, Q., & Huang, M. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114152 · Cited by 34
Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
Lai, T. T., Kim, Y. J., Ma, H.-I., & Kim, Y. E. (2022) · Journal of Movement Disorders · doi:10.14802/jmd.21078 · Cited by 32
Wu, C., Chu, C., Wang, F., Yang, H., Tseng, W.-S., Chang, C., & Chang, C. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00897-1 · Cited by 34
Russo, T., Kolisnyk, B., Aswathy, B. S., Kim, T. W., Martin, J., Plessis‐Belair, J., Ni, J., Pearson, J. A., Park, E. J., Sher, R. B., et al. (2024) · Aging Cell · doi:10.1111/acel.14077 · Cited by 32
“…cells (Figure S6b,c), known to elicit immune reactions, could potentially explain the re-ported prodromal inflammation in the midbrain of incipient PD patients and suggest that killer T-cells may be involved in the loss of DA neurons (Galiano-Landeira et al., 2020; Sulzer et al., 2017).”
BackgroundMerkler, D., Vincenti, I., Masson, F., & Liblau, R. S. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102211 · Cited by 30
Conserved and cell type-specific transcriptional responses to IFN-γ in the ventral midbrain
Hobson, B. D., Stanley, A. T., Santos, M. B. D. L., Culbertson, B., Mosharov, E. V., Sims, P. A., & Sulzer, D. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.04.008 · Cited by 31
“Further evidence suggests that T cell infiltration of the midbrain parenchyma is more common in early stage PD (Galiano-Landeira et al., 2020), but the precise role of T cells in PD pathophysiology remains unknown.”
Hepp, D. H., van Wageningen, T. A., Kuiper, K. L., van Dijk, K. D., Oosterveld, L. P., Berendse, H. W., & van de Berg, W. D. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914915 · Cited by 31
Rauschenberger, L., Behnke, J. K., Grotemeyer, A., Knörr, S., Volkmann, J., & Ip, C. W. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105798 · Cited by 30
“…at ScienceDirect Neurobiology of Disease journal homepage: www.elsevier.com/locate/ynbdi https://doi.org/10.1016/j.nbd.2022.105798 Received 11 February 2022; Received in revised form 31 May 2022; Accepted 17 June 2022 Neurobiology of Disease 171 (2022) 105798 Galiano-Landeira et al., 2020).”
InfluentialHu, S., Li, S., Ning, W., Huang, X., Liu, X., Deng, Y., Franceschi, D., Ogbuehi, A. C., Lethaus, B., Savković, V., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1032401 · Cited by 30
“In PD, the cytotoxic attack of a robust CD8+ T cell infiltration might initiate and propagate neuronal death and synucleinopathy by secreting cytolytic enzymes (granzymes A, B, and K) and/or pro-inflammatory cytokines (IFN-γ) (Galiano-Landeira et al., 2020).”
BackgroundRelationship among α‑synuclein, aging and inflammation in Parkinson's disease (Review)
Zhang, N., Yan, Z., Hua, X., Shao, S., Xue, S., Cespuglio, R., & Wang, S. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.12311 · Cited by 33
“CD8 + T cells are involved in neuronal death and α ‑Syn aggregation in PD (120).”
BackgroundMiller, M. R., Landis, H. E., Miller, R. E., & Tizabi, Y. (2024) · Cells · doi:10.3390/cells13181554 · Cited by 27
“Although α -synuclein may contribute to the disruption of the BBB [271,315], T cell infiltration appears to precede α -synuclein accumulation in the brain [233].”
BackgroundHot Topics in Recent Parkinson’s Disease Research: Where We are and Where We Should Go
Li, S., Jia, C., Li, T., & Le, W. (2021) · Neuroscience Bulletin · doi:10.1007/s12264-021-00749-x · Cited by 27
Dommershuijsen, L. J., Ruiter, R., Erler, N. S., Rizopoulos, D., Ikram, M. A., & Ikram, M. K. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212914 · Cited by 29
“Studies have shown that -synuclein can activate immune responses [3, 9, 28], but also that peripheral lymphocytes may infiltrate in the central nervous system, initiate -synuclein aggregation and stimulate uptake of -synuclein in the brain [3, 7, 28, 29].”
BackgroundIba, M., McDevitt, R. A., Kim, C., Roy, R., Sarantopoulou, D., Tommer, E., Siegars, B., Sallin, M. A., Kwon, S., Sen, J. M., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00564-6 · Cited by 26
“A Previous studies have also shown that in DLB/ PD [34–36] as well as in animal models [36, 37] ɑ -syn might trigger inflammatory responses involving T cells.”
ResultRetractedLiu, Z., Dai, H., Yao, L., Chen, W., Wang, Y., Ma, L.-Y., Li, X., Lin, S., He, M., Gao, P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39750-5 · Cited by 27
Balzano, T., del Rey, N. L., Esteban-García, N., Reinares-Sebastián, A., Pineda‐Pardo, J. A., Trigo‐Damas, I., Obeso, J. A., & Blesa, J. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00735-w · Cited by 29
Antigen‐specific and cross‐reactive T cells in protection and disease
Jiang, N. J., Malone, M. D., & Chizari, S. (2023) · Immunological Reviews · doi:10.1111/imr.13217 · Cited by 25
Yan, S., Si, Y., Zhou, W., Cheng, R., Wang, P., Wang, D., Ding, W., Shi, W., Jiang, Q., Yang, F., et al. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106801 · Cited by 26
Gonzalez-Fierro, C., Fonte, C., Dufourd, E., Cazaentre, V., Aydin, S., Engelhardt, B., Caspi, R. R., Xu, B., Martin‐Blondel, G., Spicer, J. A., et al. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200117 · Cited by 24
Sharma, P. K., Kishore, A., De, I., Negi, S., Kumar, G., Bhardwaj, S., & Singh, M. P. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105604 · Cited by 24
Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?
Furgiuele, A., Pereira, F. C., Martini, S., Marino, F., & Cosentino, M. (2023) · Clinical & Translational Immunology · doi:10.1002/cti2.1469 · Cited by 24
The role of macrophage plasticity in neurodegenerative diseases
Ma, H., Zhu, M., Chen, M., Li, X., & Feng, X. (2024) · Biomarker Research · doi:10.1186/s40364-024-00624-7 · Cited by 25
“While microglia are recognized as the primary immune cells in the CNS responsible for responding to neurological injury, studies have revealed the infiltration of peripheral immune cells into the brain of Parkinson’s disease (PD) patients [150].”
BackgroundVacchi, E., Burrello, J., Burrello, A., Bolis, S., Monticone, S., Barile, L., Kaelin‐Lang, A., & Melli, G. (2021) · Biomedicines · doi:10.3390/biomedicines9030230 · Cited by 27
“Indeed, a recent work on human substantia nigra demonstrated that CD8 T cell infiltration is an early pathogenic event and parallels the progression of neuronal loss and alpha synuclein aggregation in PD [40].”
BackgroundInnate and adaptive immunity in neurodegenerative disease
Huang, Y., Zhang, G., Li, S., Feng, J., & Zhang, Z. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05533-4 · Cited by 26
Immunogenetic Determinants of Parkinson’s Disease Etiology
Kung, P., Elsayed, I. T., Reyes‐Pérez, P., & Bandrés‐Ciga, S. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223176 · Cited by 26
“In addition, half of CD8 positive T-cells express an immune activation marker named IFN [78].”
BackgroundKeeping T cell memories in mind
Mix, M. R., & Harty, J. T. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.10.001 · Cited by 24
Mechanisms of Autoimmune Cell in DA Neuron Apoptosis of Parkinson’s Disease: Recent Advancement
Zheng, Z., Zhang, S., Zhang, H., Gao, Z., Wang, X., Liu, X., Cheng, X., Yao, L., & Lu, G. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7965433 · Cited by 23
“Subsequently, their density of CD8+ T cells positively correlated with neuronal death [29].”
Poxleitner, M., Hoffmann, S. H. L., Berezhnoy, G., Ionescu, T. M., González-Menéndez, I., Maier, F. C., Seyfried, D., Ehrlichmann, W., Quintanilla‐Martínez, L., Schmid, A. M., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03080-0 · Cited by 23
Huang, Y., Liu, H., Hu, J., Han, C., Zhong, Z., Luo, W., Zhang, Y., & Ling, F. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.686066 · Cited by 24
The Innate and Adaptive Immune Cells in Alzheimer’s and Parkinson’s Diseases
Huang, B., Zhenxin, Y., Chen, S., Tan, Z., Zong, Z., Zhang, H., & Xiong, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1315248 · Cited by 23
“It was found that CD8+ T cells infiltrated into the brain in response to increased α-Syn levels, which was early in the disease course prior to significant DA loss [118, 119].”
BackgroundNeuroinflammation in neurodegenerative diseases: Focusing on the mediation of T lymphocytes
Li, K., Chen, R., Wang, R., Fan, W., Zhao, N., Yang, Z., & Yan, J. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01539 · Cited by 24
“Numerous publications have addressed the alterations seen in CD8 + T cells in PD. PD patients exhibit an increased number of CD8 + T cells, and this elevation is positively associated with neuronal death (Galiano-Landeira et al., 2020).”
Age-Related Adaptive Immune Changes in Parkinson’s Disease
Kouli, A., & Williams-Gray, C. H. (2022) · Journal of Parkinson's Disease · doi:10.3233/jpd-223228 · Cited by 20
The role of T-lymphocytes in central nervous system diseases
Shen, J., Bian, N., Zhao, L., & Wei, J. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.110904 · Cited by 22
“TNF-α , in particular, is a key mediator of inflammation in the CNS, with elevated levels observed in various CNS pathologies, including neurodegenerative diseases (AD (Decourt et al., 2017), PD (Liu et al., 2022), and HD (M ¨ oller, 2010; Chambon et al., 2023)), acute injuries (stroke (Chen et…”
BackgroundFundamental mechanistic insights from rare but paradigmatic neuroimmunological diseases
Wiendl, H., Groß, C. C., Bauer, J., Merkler, D., Prat, A., & Liblau, R. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00496-7 · Cited by 20
Rabaneda‐Lombarte, N., Vidal-Taboada, J. M., Valente, T., Ezquerra, M., Fernández‐Santiago, R., Martí, M. J., Compta, Y., Saura, J., & Solà, C. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00290-2 · Cited by 19
Growth arrest and DNA damage-inducible 45: a new player on inflammatory diseases
Ma, Y., Hossen, M. M., Huang, J. J., Yin, Z., Du, J., Ye, Z., Zeng, M., & Huang, Z. W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1513069 · Cited by 22
Midbrain cytotoxic T cells as a distinct neuropathological feature of progressive supranuclear palsy
Couto, B., Forrest, S. L., Fearon, C., Lee, S., Knott, S., Li, J., Fox, S. H., Tartaglia, M. C., Lang, A. E., & Kovács, G. G. (2025) · Brain · doi:10.1093/brain/awaf135 · Cited by 20
CD8 T cells as drivers of blood–brain barrier disruption
Seady, M., & Johnson, A. J. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.05.008 · Cited by 18
Tumpa, J. J., Hayder, Q. U. A., Maisa, N. S., & Islam, M. N. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1682006 · Cited by 18
Epigenome-wide association study of peripheral immune cell populations in Parkinson’s disease
Andersen, M. S., Leikfoss, I. S., Brorson, I. S., Cappelletti, C., Bettencourt, C., Toft, M., & Pihlstrøm, L. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00594-x · Cited by 20
Pramanik, S., Harini Devi, M., Chakrabarty, S., Paylar, B., Pradhan, A., Thaker, M., Ayyadhury, S., Manavalan, A., Olsson, P., Pramanik, G., et al. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105834 · Cited by 20
McFleder, R. L., Musacchio, T., Keller, J., Knörr, S., Petschner, T., Chen, J. Z., Muthuraman, M., Badr, M., Rauschenberger, L., Kremer, F., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.10.039 · Cited by 18
Metadata
- Authors
- Galiano-Landeira, J., Torra, A., Vila, M., & Bové, J.
- Affiliations
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Corresponding author
- Bové, Jordi
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-10-29
- Volume
- 143
- Issue
- 12
- Pages
- 3717-3733
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W3096763885
- Cited by
- 267
- References
- 62
- Citations by year
- 2026: 43 · 2025: 51 · 2024: 64 · 2023: 46 · 2022: 42 · 2021: 20 · 2020: 1
- FWCI
- 11.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fondo de Investigación Sanitaria-Instituto de Salud Carlos III (PI15/01937, PI18/01894)
- European Union, and Pla Estratègic de Recerca i Innovació en salut-Departament de Salut Generalitat de Catalunya (SLT006/17/00258)
- Ministry of Economy and Competitiveness (SAF2016-77541-R)
- “la Caixa” Foundation (100010434, LCF/PR/HR17/52150003)
- Fondo de Investigación Sanitaria- Instituto de Salud Carlos III
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- CD8+ T cells, T cell infiltration, substantia nigra pars compacta, synucleinopathies, alpha-synuclein aggregation, dopaminergic neuron loss, incidental Lewy body disease, tissue-resident memory T cells, granzymes, interferon-gamma, adaptive immune response, neuroinflammation, cytotoxic T lymphocytes, presymptomatic disease
- MeSH terms
- Synucleinopathies, Aged, Aged, 80 and over, Brain, Cytotoxins, Female, Humans, Immunohistochemistry, Immunologic Surveillance, Male, Neurons, Parkinson Disease, Substantia Nigra, Cytokines, Cell Death, CD8-Positive T-Lymphocytes, Disease Progression, Lewy Body Disease, alpha-Synuclein, Granzymes, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.